{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T23:35:48Z","timestamp":1792884948446,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Institute of Advanced Industrial Science and Technology","id":[{"id":"https:\/\/ror.org\/01703db54","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00210-026-05621-1","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T06:10:04Z","timestamp":1782972604000},"page":"20303-20321","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular insights into the anti-COVID-19 activity of reduced (quinol) and oxidized (quinone) forms of coenzyme Q10"],"prefix":"10.1007","volume":"399","author":[{"given":"Mangala","family":"Hegde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipul","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharmender","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Terao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil C.","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shudhanshu","family":"Vrati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durai","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renu","family":"Wadhwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajaikumar B.","family":"Kunnumakkara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"5621_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110627","volume":"130","author":"A Abdeen","year":"2020","unstructured":"Abdeen A, Abdelkader A, Elgazzar D, Aboubakr M, Abdulah OA, Shoghy K, Abdel-Daim M, El-Serehy HA, Najda A, El-Mleeh A (2020) Coenzyme Q10 supplementation mitigates piroxicam-induced oxidative injury and apoptotic pathways in the stomach, liver, and kidney. Biomed Pharmacother 130:110627","journal-title":"Biomed Pharmacother"},{"key":"5621_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-023-02210-z","volume":"20","author":"S Aboul-Fotouh","year":"2023","unstructured":"Aboul-Fotouh S, Mahmoud AN, Elnahas EM, Habib MZ, Abdelraouf SM (2023) What are the current anti-COVID-19 drugs? From traditional to smart molecular mechanisms. Virol J 20:241","journal-title":"Virol J"},{"key":"5621_CR3","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.2174\/1568026623666230327125918","volume":"23","author":"V Aggarwal","year":"2023","unstructured":"Aggarwal V, Bala E, Kumar P, Raizada P, Singh P, Verma PK (2023) Natural products as potential therapeutic agents for SARS-CoV-2: a medicinal chemistry perspective. Curr Top Med Chem 23:1664\u20131698","journal-title":"Curr Top Med Chem"},{"key":"5621_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2174\/1573409919666221117145404","volume":"19","author":"V Alagarsamy","year":"2023","unstructured":"Alagarsamy V, Solomon VR, Sundar PS, Kulkarni VS, Sulthana MT, Aishwarya AD, Narendhar B, Murugesan S (2023) Computational search for potential COVID-19 drugs from ayurvedic medicinal plants to identify potential inhibitors against SARS-CoV-2 targets. Curr Comput Aided Drug Des 19:51\u201367","journal-title":"Curr Comput Aided Drug Des"},{"key":"5621_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118346","volume":"189","author":"M Al-Khrasani","year":"2025","unstructured":"Al-Khrasani M, Essmat N, Boldizsar I Jr., Varga BT, Chalabiani Y, Abbood SK, Ernyey AJ, Kiraly K, Mate A, Riba P, Timar J, Gyertyan I, Miklya I, Parenti C, Pasquinucci L, Agg B, Furst S, Ferdinandy P, Vizi ES, Harsing LG Jr. (2025) Do vitamins halt the COVID-19-evoked pro-inflammatory cytokines involved in the development of neuropathic pain? Biomed Pharmacother 189:118346","journal-title":"Biomed Pharmacother"},{"key":"5621_CR6","doi-asserted-by":"publisher","DOI":"10.1155\/sci5\/3687892","volume":"2025","author":"K Baby","year":"2025","unstructured":"Baby K, Vithalkar MP, Dastidar SG, Mukhopadhyay C, Hamdy R, Soliman SSM, Nayak Y (2025) Exploring TMPRSS2 drug target to combat influenza and coronavirus infection. Scientifica (Cairo) 2025:3687892","journal-title":"Scientifica (Cairo)"},{"key":"5621_CR7","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.2147\/DDDT.S308863","volume":"15","author":"OA Badary","year":"2021","unstructured":"Badary OA, Hamza MS, Tikamdas R (2021) Thymoquinone: a promising natural compound with potential benefits for COVID-19 prevention and cure. Drug Des Devel Ther 15:1819\u20131833","journal-title":"Drug Des Devel Ther"},{"key":"5621_CR8","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1038\/s41467-025-57905-4","volume":"16","author":"SM Bader","year":"2025","unstructured":"Bader SM, Calleja DJ, Devine SM, Kuchel NW, Lu BGC, Wu X, Birkinshaw RW, Bhandari R, Loi K, Volpe R, Khakham Y, Au AE, Blackmore TR, Mackiewicz L, Dayton M, Schaefer J, Scherer L, Stock AT, Cooney JP, Schoffer K, Maluenda A, Kleeman EA, Davidson KC, Allison CC, Ebert G, Chen G, Katneni K, Klemm TA, Nachbur U, Georgy SR, Czabotar PE, Hannan AJ, Putoczki TL, Tanzer M, Pellegrini M, Lechtenberg BC, Charman SA, Call MJ, Mitchell JP, Lowes KN, Lessene G, Doerflinger M, Komander D (2025) A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID. Nat Commun 16:2900","journal-title":"Nat Commun"},{"key":"5621_CR9","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s10238-022-00871-8","volume":"23","author":"MA Barletta","year":"2023","unstructured":"Barletta MA, Marino G, Spagnolo B, Bianchi FP, Falappone PCF, Spagnolo L, Gatti P (2023) Coenzyme Q10 + alpha lipoic acid for chronic COVID syndrome. Clin Exp Med 23:667\u2013678","journal-title":"Clin Exp Med"},{"key":"5621_CR10","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1016\/j.jiph.2020.09.015","volume":"13","author":"F Caruso","year":"2020","unstructured":"Caruso F, Rossi M, Pedersen JZ, Incerpi S (2020) Computational studies reveal mechanism by which quinone derivatives can inhibit SARS-CoV-2. Study of embelin and two therapeutic compounds of interest, methyl prednisolone and dexamethasone. J Infect Public Health 13:1868\u20131877","journal-title":"J Infect Public Health"},{"key":"5621_CR11","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1080\/07315724.2001.10719063","volume":"20","author":"FL Crane","year":"2001","unstructured":"Crane FL (2001) Biochemical functions of coenzyme Q10. J Am Coll Nutr 20:591\u2013598","journal-title":"J Am Coll Nutr"},{"key":"5621_CR12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","volume":"1263","author":"S Dallakyan","year":"2015","unstructured":"Dallakyan S, Olson AJ (2015) Small-molecule library screening by docking with PyRx. Methods Mol Biol 1263:243\u2013250","journal-title":"Methods Mol Biol"},{"key":"5621_CR13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","volume":"21","author":"HE Davis","year":"2023","unstructured":"Davis HE, McCorkell L, Vogel JM, Topol EJ (2023) Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 21:133\u2013146","journal-title":"Nat Rev Microbiol"},{"key":"5621_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2022.963701","volume":"10","author":"X Duan","year":"2022","unstructured":"Duan X, Lacko LA, Chen S (2022) Druggable targets and therapeutic development for COVID-19. Front Chem 10:963701","journal-title":"Front Chem"},{"key":"5621_CR15","doi-asserted-by":"publisher","first-page":"233","DOI":"10.34172\/apb.2023.026","volume":"13","author":"M Fakhrolmobasheri","year":"2023","unstructured":"Fakhrolmobasheri M, Hosseini MS, Shahrokh SG, Mohammadi Z, Kahlani MJ, Majidi SE, Zeinalian M (2023) Coenzyme Q10 and its therapeutic potencies against COVID-19 and other similar infections: a molecular review. Adv Pharm Bull 13:233\u2013243","journal-title":"Adv Pharm Bull"},{"key":"5621_CR16","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.phrs.2017.01.032","volume":"119","author":"L Fan","year":"2017","unstructured":"Fan L, Feng Y, Chen G-C, Qin L-Q, Fu C-l, Chen L-H (2017) Effects of coenzyme Q10 supplementation on inflammatory markers: a systematic review and meta-analysis of randomized controlled trials. Pharmacol Res 119:128\u2013136","journal-title":"Pharmacol Res"},{"key":"5621_CR17","first-page":"775","volume":"121","author":"A Gvozdjakova","year":"2020","unstructured":"Gvozdjakova A, Klauco F, Kucharska J, Sumbalova Z (2020) Is mitochondrial bioenergetics and coenzyme Q10 the target of a virus causing COVID-19? Bratisl Lek Listy 121:775\u2013778","journal-title":"Bratisl Lek Listy"},{"key":"5621_CR18","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/978-3-030-71697-4_13","volume":"1327","author":"IR Hargreaves","year":"2021","unstructured":"Hargreaves IR, Mantle D (2021) COVID-19, coenzyme Q10 and selenium. Adv Exp Med Biol 1327:161\u2013168","journal-title":"Adv Exp Med Biol"},{"key":"5621_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.00044","volume":"9","author":"JD Hernandez-Camacho","year":"2018","unstructured":"Hernandez-Camacho JD, Bernier M, Lopez-Lluch G, Navas P (2018) Coenzyme Q(10) supplementation in aging and disease. Front Physiol 9:44","journal-title":"Front Physiol"},{"key":"5621_CR20","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1126\/science.abn2222","volume":"375","author":"EC Holmes","year":"2022","unstructured":"Holmes EC (2022) COVID-19\u2014lessons for zoonotic disease. Science 375:1114\u20131115","journal-title":"Science"},{"key":"5621_CR21","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1002\/ptr.6895","volume":"35","author":"MN Islam","year":"2021","unstructured":"Islam MN, Hossain KS, Sarker PP, Ferdous J, Hannan MA, Rahman MM, Chu DT, Uddin MJ (2021) Revisiting pharmacological potentials of Nigella sativa seed: a promising option for COVID-19 prevention and cure. Phytother Res 35:1329\u20131344","journal-title":"Phytother Res"},{"key":"5621_CR22","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.68165","author":"A Israel","year":"2021","unstructured":"Israel A, Schaffer AA, Cicurel A, Cheng K, Sinha S, Schiff E, Feldhamer I, Tal A, Lavie G, Ruppin E (2021) Identification of drugs associated with reduced severity of COVID-19 - a case-control study in a large population. eLife. https:\/\/doi.org\/10.7554\/eLife.68165","journal-title":"eLife"},{"key":"5621_CR23","first-page":"61","volume":"57","author":"COM Jasirwan","year":"2025","unstructured":"Jasirwan COM, Purnamasari D, Widhani A, Kamila T (2025) Outcome of patients with metabolic-associated fatty liver disease who are infected with SARS-CoV-2: a meta-analysis. Acta Med Indones 57:61\u201373","journal-title":"Acta Med Indones"},{"key":"5621_CR24","doi-asserted-by":"publisher","first-page":"5917","DOI":"10.1080\/07391102.2021.1875050","volume":"40","author":"NN Junior","year":"2022","unstructured":"Junior NN, Santos IA, Meireles BA, Nicolau MSP, Lapa IR, Aguiar RS, Jardim ACG, Jose DP (2022) In silico evaluation of lapachol derivatives binding to the Nsp9 of SARS-CoV-2. J Biomol Struct Dyn 40:5917\u20135931","journal-title":"J Biomol Struct Dyn"},{"key":"5621_CR25","doi-asserted-by":"publisher","first-page":"570","DOI":"10.2174\/1570163817666200712164406","volume":"18","author":"Y Kadil","year":"2021","unstructured":"Kadil Y, Mouhcine M, Filali H (2021) In silico investigation of the SARS CoV2 protease with thymoquinone, the major constituent of Nigella sativa. Curr Drug Discov Technol 18:570\u2013573","journal-title":"Curr Drug Discov Technol"},{"key":"5621_CR26","doi-asserted-by":"publisher","first-page":"7885","DOI":"10.1080\/07391102.2021.1902858","volume":"40","author":"RS Kalra","year":"2022","unstructured":"Kalra RS, Kumar V, Dhanjal JK, Garg S, Li X, Kaul SC, Sundar D, Wadhwa R (2022) COVID19-inhibitory activity of withanolides involves targeting of the host cell surface receptor ACE2: insights from computational and biochemical assays. J Biomol Struct Dyn 40:7885\u20137898","journal-title":"J Biomol Struct Dyn"},{"key":"5621_CR27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.freeradbiomed.2023.06.018","volume":"206","author":"Y Kato","year":"2023","unstructured":"Kato Y, Sakanishi A, Matsuda K, Hattori M, Kaneko I, Nishikawa M, Ikushiro S (2023) Covalent adduction of serotonin-derived quinones to the SARS-CoV-2 main protease expressed in a cultured cell. Free Radic Biol Med 206:74\u201382","journal-title":"Free Radic Biol Med"},{"key":"5621_CR28","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.2174\/1389201021999201110205048","volume":"22","author":"MA Khan","year":"2021","unstructured":"Khan MA, Younus H (2021) Potential implications of black seed and its principal constituent thymoquinone in the treatment of COVID-19 patients. Curr Pharm Biotechnol 22:1315\u20131324","journal-title":"Curr Pharm Biotechnol"},{"key":"5621_CR29","doi-asserted-by":"publisher","first-page":"e250667","DOI":"10.1590\/1519-6984.25066","volume":"84","author":"MT Khan","year":"2022","unstructured":"Khan MT, Ali A, Wei X, Nadeem T, Muhammad S, Al-Sehemi AG, Wei D (2022) Inhibitory effect of thymoquinone from Nigella sativa against SARS-CoV-2 main protease. An in-silico study. Braz J Biol 84:e250667","journal-title":"Braz J Biol"},{"key":"5621_CR30","doi-asserted-by":"publisher","DOI":"10.2174\/0109298673271674231109052709","author":"MA Khanfar","year":"2023","unstructured":"Khanfar MA, Saleh MI (2023) SARS-CoV-2 main protease inhibitors from natural product repository as therapeutic candidates for the treatment of coronaviridae infections. Curr Med Chem. https:\/\/doi.org\/10.2174\/0109298673271674231109052709","journal-title":"Curr Med Chem"},{"key":"5621_CR31","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1080\/13880209.2021.1931353","volume":"59","author":"MR Khazdair","year":"2021","unstructured":"Khazdair MR, Ghafari S, Sadeghi M (2021) Possible therapeutic effects of Nigella sativa and its thymoquinone on COVID-19. Pharm Biol 59:696\u2013703","journal-title":"Pharm Biol"},{"key":"5621_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2020.153277","volume":"85","author":"MF Kulyar","year":"2021","unstructured":"Kulyar MF, Li R, Mehmood K, Waqas M, Li K, Li J (2021) Potential influence of Nagella sativa (Black cumin) in reinforcing immune system: a hope to decelerate the COVID-19 pandemic. Phytomedicine 85:153277","journal-title":"Phytomedicine"},{"key":"5621_CR33","doi-asserted-by":"publisher","first-page":"3842","DOI":"10.1080\/07391102.2020.1772108","volume":"39","author":"V Kumar","year":"2021","unstructured":"Kumar V, Dhanjal JK, Kaul SC, Wadhwa R, Sundar D (2021) Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (M(pro)) of SARS-CoV-2 and inhibit its activity. J Biomol Struct Dyn 39:3842\u20133854","journal-title":"J Biomol Struct Dyn"},{"key":"5621_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2020.1775704","volume":"40","author":"V Kumar","year":"2022","unstructured":"Kumar V, Dhanjal JK, Bhargava P, Kaul A, Wang J, Zhang H, Kaul SC, Wadhwa R, Sundar D (2022) Withanone and withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells. J Biomol Struct Dyn 40:1\u201313","journal-title":"J Biomol Struct Dyn"},{"key":"5621_CR35","doi-asserted-by":"publisher","first-page":"830","DOI":"10.2174\/0115680266280720231221100004","volume":"24","author":"V Kumar","year":"2024","unstructured":"Kumar V, Sari AN, Gupta D, Ishida Y, Terao K, Kaul SC, Vrati S, Sundar D, Wadhwa R (2024) Anti-COVID-19 potential of withaferin-A and caffeic acid phenethyl ester. Curr Top Med Chem 24:830\u2013842","journal-title":"Curr Top Med Chem"},{"key":"5621_CR36","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1080\/08923973.2022.2037631","volume":"44","author":"AD Kushwaha","year":"2022","unstructured":"Kushwaha AD, Mishra KP, Singh M, Ganju L, Saraswat D (2022) Nanocurcumin formulation: a possible therapeutic agent for post COVID inflammatory syndrome. Immunopharmacol Immunotoxicol 44:141\u2013146","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"5621_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/biom15091339","author":"E Lee","year":"2025","unstructured":"Lee E, Ozigbo AA, Varon J, Halma M, Laezzo M, Ang SP, Iglesias J (2025) Mitochondrial reactive oxygen species: a unifying mechanism in long COVID and spike protein-associated injury: a narrative review. Biomolecules. https:\/\/doi.org\/10.3390\/biom15091339","journal-title":"Biomolecules"},{"key":"5621_CR38","doi-asserted-by":"publisher","DOI":"10.15252\/embj.20105114","volume":"39","author":"S Lukassen","year":"2020","unstructured":"Lukassen S, Chua RL, Trefzer T, Kahn NC, Schneider MA, Muley T, Winter H, Meister M, Veith C, Boots AW, Hennig BP, Kreuter M, Conrad C, Eils R (2020) SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells. EMBO J 39:e105114","journal-title":"EMBO J"},{"key":"5621_CR39","doi-asserted-by":"publisher","unstructured":"Malik V, Kumar V, Kaul SC, Wadhwa R, Sundar D (2021) Potential of Withaferin-A, Withanone and Caffeic Acid Phenethyl ester as ATP-competitive inhibitors of BRAF: A bioinformatics study. Curr Res Struct Biol 3:301\u2013311. https:\/\/doi.org\/10.1016\/j.crstbi.2021.11.004","DOI":"10.1016\/j.crstbi.2021.11.004"},{"key":"5621_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26125788","author":"D Mantle","year":"2025","unstructured":"Mantle D, Golomb BA (2025) Coenzyme Q10 and xenobiotic metabolism: an overview. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26125788","journal-title":"Int J Mol Sci"},{"key":"5621_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25010574","author":"D Mantle","year":"2024","unstructured":"Mantle D, Hargreaves IP, Domingo JC, Castro-Marrero J (2024) Mitochondrial dysfunction and coenzyme Q10 supplementation in post-viral fatigue syndrome: an overview. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25010574","journal-title":"Int J Mol Sci"},{"key":"5621_CR42","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01648-20","author":"S Matsuyama","year":"2020","unstructured":"Matsuyama S, Kawase M, Nao N, Shirato K, Ujike M, Kamitani W, Shimojima M, Fukushi S (2020) The inhaled steroid ciclesonide blocks SARS-CoV-2 RNA replication by targeting the viral replication-transcription complex in cultured cells. J Virol. https:\/\/doi.org\/10.1128\/JVI.01648-20","journal-title":"J Virol"},{"key":"5621_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2020.111147","volume":"142","author":"DJ Moreno Fernandez-Ayala","year":"2020","unstructured":"Moreno Fernandez-Ayala DJ, Navas P, Lopez-Lluch G (2020) Age-related mitochondrial dysfunction as a key factor in COVID-19 disease. Exp Gerontol 142:111147","journal-title":"Exp Gerontol"},{"key":"5621_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2025.110607","volume":"610","author":"SA Mothae","year":"2025","unstructured":"Mothae SA, Chiliza TE, Mvubu NE (2025) SARS-CoV-2 host-pathogen interactome: insights into more players during pathogenesis. Virology 610:110607","journal-title":"Virology"},{"key":"5621_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2020.110161","volume":"144","author":"L Ouyang","year":"2020","unstructured":"Ouyang L, Gong J (2020) Mitochondrial-targeted ubiquinone: a potential treatment for COVID-19. Med Hypotheses 144:110161","journal-title":"Med Hypotheses"},{"key":"5621_CR46","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1126\/science.abl4784","volume":"374","author":"DR Owen","year":"2021","unstructured":"Owen DR, Allerton CMN, Anderson AS, Aschenbrenner L, Avery M, Berritt S, Boras B, Cardin RD, Carlo A, Coffman KJ, Dantonio A, Di L, Eng H, Ferre R, Gajiwala KS, Gibson SA, Greasley SE, Hurst BL, Kadar EP, Kalgutkar AS, Lee JC, Lee J, Liu W, Mason SW, Noell S, Novak JJ, Obach RS, Ogilvie K, Patel NC, Pettersson M, Rai DK, Reese MR, Sammons MF, Sathish JG, Singh RSP, Steppan CM, Stewart AE, Tuttle JB, Updyke L, Verhoest PR, Wei L, Yang Q, Zhu Y (2021) An oral SARS-CoV-2 M(pro) inhibitor clinical candidate for the treatment of COVID-19. Science 374:1586\u20131593","journal-title":"Science"},{"key":"5621_CR47","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00011-020-01423-0","volume":"70","author":"G Pagano","year":"2021","unstructured":"Pagano G, Manfredi C, Pallardo FV, Lyakhovich A, Tiano L, Trifuoggi M (2021) Potential roles of mitochondrial cofactors in the adjuvant mitigation of proinflammatory acute infections, as in the case of sepsis and COVID-19 pneumonia. Inflamm Res 70:159\u2013170","journal-title":"Inflamm Res"},{"key":"5621_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23010128","volume":"23","author":"F Pallotti","year":"2022","unstructured":"Pallotti F, Bergamini C, Lamperti C, Fato R (2022) The roles of coenzyme Q in disease: direct and indirect involvement in cellular functions. Int J Mol Sci 23:128","journal-title":"Int J Mol Sci"},{"key":"5621_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2025.108454","volume":"119","author":"AM Rabie","year":"2025","unstructured":"Rabie AM, Khedraoui M, Chtita S (2025) Targeting conserved regions of the SARS-CoV-2 polymerase (RdRp) with kinase inhibitors as an effective new tactic for discovering dual-action \u201cantiviral-antiinflammatory\u201d drugs against COVID-19. Comput Biol Chem 119:108454","journal-title":"Comput Biol Chem"},{"key":"5621_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens14080820","author":"M Raekiansyah","year":"2025","unstructured":"Raekiansyah M, Ngwe Tun MM, Ang A, Lee A, Macalino SJ, Billones J, Takamatsu Y, Urano T, Murao LAE, Quiming N, Morita K, Carrillo MC (2025) Antiviral activity of medicinal plant extracts Vitex negundo and Macaranga tanarius against SARS-CoV-2. Pathogens (Basel). https:\/\/doi.org\/10.3390\/pathogens14080820","journal-title":"Pathogens (Basel)"},{"key":"5621_CR51","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1124\/mol.114.094862","volume":"86","author":"BM Rock","year":"2014","unstructured":"Rock BM, Hengel SM, Rock DA, Wienkers LC, Kunze KL (2014) Characterization of ritonavir-mediated inactivation of cytochrome P450 3A4. Mol Pharmacol 86:665\u2013674","journal-title":"Mol Pharmacol"},{"key":"5621_CR52","doi-asserted-by":"publisher","DOI":"10.1177\/00368504251322069","volume":"108","author":"I Saha","year":"2025","unstructured":"Saha I, Banerjee O, Sarkar Biswas S, Mukherjee S (2025) COVID-19 beyond the lungs: unraveling its vascular impact and cardiovascular complications-mechanisms and therapeutic implications. Sci Prog 108:368504251322069","journal-title":"Sci Prog"},{"key":"5621_CR53","doi-asserted-by":"publisher","DOI":"10.1128\/mmbr.00260-24","volume":"89","author":"I Santamaria-Castro","year":"2025","unstructured":"Santamaria-Castro I, Leiva-Rebollo R, Marin-Wong S, Jimenez-Guardeno JM, Ortega-Prieto AM (2025) Molecular mechanisms of SARS-CoV-2 entry: implications for biomedical strategies. Microbiol Mol Biol Rev 89:e0026024","journal-title":"Microbiol Mol Biol Rev"},{"key":"5621_CR54","unstructured":"Schr\u00f6dinger (2020) Schr\u00f6dinger Release 2020\u20131: Maestro 019\u20133\u2009SR, G., LigPrep, Protein Preparation Wizard, Prime, Desmond Molecular Dynamics System, Maestro-Desmond Interoperability Tools. Schr\u00f6dinger, LLC."},{"key":"5621_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.phytochem.2021.112854","volume":"190","author":"RB Semwal","year":"2021","unstructured":"Semwal RB, Semwal DK, Combrinck S, Viljoen A (2021) Emodin - a natural anthraquinone derivative with diverse pharmacological activities. Phytochemistry 190:112854","journal-title":"Phytochemistry"},{"key":"5621_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare10030487","volume":"10","author":"S Sifuentes-Franco","year":"2022","unstructured":"Sifuentes-Franco S, S\u00e1nchez-Mac\u00edas DC, Carrillo-Ibarra S, Rivera-Vald\u00e9s JJ, Zu\u00f1iga LY, S\u00e1nchez-L\u00f3pez VA (2022) Antioxidant and anti-inflammatory effects of coenzyme Q10 supplementation on infectious diseases. Healthcare (Basel) 10:487","journal-title":"Healthcare (Basel)"},{"key":"5621_CR57","first-page":"9","volume":"123","author":"Z Sumbalova","year":"2022","unstructured":"Sumbalova Z, Kucharska J, Palacka P, Rausova Z, Langsjoen PH, Langsjoen AM, Gvozdjakova A (2022) Platelet mitochondrial function and endogenous coenzyme Q10 levels are reduced in patients after COVID-19. Bratisl Lek Listy 123:9\u201315","journal-title":"Bratisl Lek Listy"},{"key":"5621_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70829","volume":"14","author":"X Tang","year":"2025","unstructured":"Tang X, Lu L, Li X, Huang P (2025) Bridging cancer and COVID-19: the complex interplay of ACE2 and TMPRSS2. Cancer Med 14:e70829","journal-title":"Cancer Med"},{"key":"5621_CR59","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.2174\/1389557522666220104151225","volume":"22","author":"S Taysi","year":"2022","unstructured":"Taysi S, Algburi FS, Mohammed ZR, Ali OA, Taysi ME (2022) Thymoquinone: a review on its pharmacological importance, and its association with oxidative stress, COVID-19, and radiotherapy. Mini Rev Med Chem 22:1847\u20131875","journal-title":"Mini Rev Med Chem"},{"key":"5621_CR60","doi-asserted-by":"publisher","first-page":"8791","DOI":"10.1007\/s12010-024-04994-4","volume":"196","author":"R Wadhwa","year":"2024","unstructured":"Wadhwa R, Hegde M, Zhang H, Kaul A, Wang J, Ishida Y, Terao K, Kunnumakkara AB, Kaul SC (2024) Antistress and antiaging potentials of alpha-lipoic acid: insights from cell culture-based experiments. Appl Biochem Biotechnol 196:8791\u20138808","journal-title":"Appl Biochem Biotechnol"},{"key":"5621_CR61","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1093\/bioinformatics\/bty879","volume":"35","author":"Z Wang","year":"2019","unstructured":"Wang Z, Wang X, Li Y, Lei T, Wang E, Li D, Kang Y, Zhu F, Hou T (2019) FarPPI: a webserver for accurate prediction of protein-ligand binding structures for small-molecule PPI inhibitors by MM\/PB(GB)SA methods. Bioinformatics 35:1777\u20131779","journal-title":"Bioinformatics"},{"key":"5621_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232012345","author":"R Wang","year":"2022","unstructured":"Wang R, Chen Y, Tian Z, Zhu M, Zhang B, Du S, Li Y, Liu Z, Hou S, Yang Y (2022) Coenzyme Q10 attenuates human platelet aggregation induced by SARS-CoV-2 spike protein via reducing oxidative stress in vitro. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232012345","journal-title":"Int J Mol Sci"},{"key":"5621_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2025.130243","volume":"124","author":"P Zheng","year":"2025","unstructured":"Zheng P, Li G, Chen Y, Li S, Yang S, Guo D, Zhou Q, Zhang X (2025) Mini review: SHEN26, a novel oral antiviral drug for COVID-19 treatment. Bioorg Med Chem Lett 124:130243","journal-title":"Bioorg Med Chem Lett"},{"key":"5621_CR64","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jtos.2020.06.007","volume":"18","author":"L Zhou","year":"2020","unstructured":"Zhou L, Xu Z, Castiglione GM, Soiberman US, Eberhart CG, Duh EJ (2020) ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection. Ocul Surf 18:537\u2013544","journal-title":"Ocul Surf"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05621-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05621-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05621-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T23:02:42Z","timestamp":1792882962000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05621-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":64,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["5621"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05621-1","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"assertion":[{"value":"9 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}]}}